Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Buprenorphine.

Foster B, Twycross R, Mihalyo M, Wilcock A.

J Pain Symptom Manage. 2013 May;45(5):939-49. doi: 10.1016/j.jpainsymman.2013.03.001. No abstract available.

PMID:
23648060
2.

Buprenorphine for chronic pain.

Calderon R, Copenhaver D.

J Pain Palliat Care Pharmacother. 2013 Dec;27(4):402-5. doi: 10.3109/15360288.2013.847522. Epub 2013 Nov 18.

PMID:
24245573
3.

Clarification on transdermal buprenorphine.

Dankiewicz EH, Haddox JD.

J Pain Palliat Care Pharmacother. 2014 Dec;28(4):415-6. doi: 10.3109/15360288.2014.972489. Epub 2014 Oct 28. No abstract available.

PMID:
25348227
4.

[Buprenorphine transdermal patch (Norspan tape)].

Hamaguchi S, Ikeda T.

Masui. 2013 Jul;62(7):799-807. Japanese.

PMID:
23905402
5.

Buprenorphine buccal film (Belbuca) for chronic pain.

[No authors listed]

Med Lett Drugs Ther. 2016 Apr 11;58(1492):47-8. No abstract available.

PMID:
27049508
6.

Anti-hyperalgesia properties of buprenorphine.

Russo MA.

Pain. 2006 May;122(1-2):216; author reply 216. Epub 2006 Mar 9. No abstract available.

PMID:
16524662
7.

[Is anti-hyperalgesia clinically relevant? Dosage increase is hardly necessary].

[No authors listed]

MMW Fortschr Med. 2006 Jan 12;148(1-2):43. German. No abstract available.

PMID:
16610415
8.

[Pain therapy in the elderly:7-day transdermal buprenorphine patch in clinical practice. Results of a non-interventional study].

Wahle K, Krings D, Schwenke K.

MMW Fortschr Med. 2013 Mar 21;155 Suppl 1:25-31. Review. German.

PMID:
23678668
9.

Opioids: from analgesia to anti-hyperalgesia?

Simonnet G.

Pain. 2005 Nov;118(1-2):8-9. Epub 2005 Oct 3. No abstract available.

PMID:
16202525
10.

Conversion of chronic pain patients from full-opioid agonists to sublingual buprenorphine.

Daitch J, Frey ME, Silver D, Mitnick C, Daitch D, Pergolizzi J Jr.

Pain Physician. 2012 Jul;15(3 Suppl):ES59-66.

11.

Transdermal buprenorphine (Butrans) for chronic pain.

[No authors listed]

Med Lett Drugs Ther. 2011 Apr 18;53(1362):31-2.

PMID:
21502936
12.

Different profiles of buprenorphine-induced analgesia and antihyperalgesia in a human pain model.

Koppert W, Ihmsen H, Körber N, Wehrfritz A, Sittl R, Schmelz M, Schüttler J.

Pain. 2005 Nov;118(1-2):15-22. Epub 2005 Sep 9.

PMID:
16154698
13.

Opioid-induced hyperalgesia--worsening pain in opioid-dependent patients.

Varney SM, Bebarta VS.

Am J Emerg Med. 2013 Feb;31(2):458.e5-6. doi: 10.1016/j.ajem.2012.07.031. Epub 2012 Oct 5. No abstract available.

PMID:
23041481
14.

Efficacy and safety of buprenorphine transdermal system (BTDS) for chronic moderate to severe low back pain: a randomized, double-blind study.

Steiner D, Munera C, Hale M, Ripa S, Landau C.

J Pain. 2011 Nov;12(11):1163-73. doi: 10.1016/j.jpain.2011.06.003. Epub 2011 Jul 31.

PMID:
21807566
15.

[Buprenorphine matrix patch well tolerated. The challenge of tumor pain].

[No authors listed]

MMW Fortschr Med. 2006 Jan 12;148(1-2):42-3. German. No abstract available.

PMID:
16612846
16.

Allergic contact dermatitis due to transdermal buprenorphine.

Pérez-Pérez L, Cabanillas M, Loureiro M, Fernández-Redondo V, Labandeira J, Toribio J.

Contact Dermatitis. 2008 May;58(5):310-2. doi: 10.1111/j.1600-0536.2007.01206.x. No abstract available.

PMID:
18416765
17.

Allergic contact dermatitis from buprenorphine.

Callejo Melgosa AM, Martínez JC, Fuentes MJ, Martín C.

Allergy. 2005 Sep;60(9):1217-8. No abstract available.

18.

Buprenorphine maintenance therapy hinders acute pain management in trauma.

Harrington CJ, Zaydfudim V.

Am Surg. 2010 Apr;76(4):397-9.

PMID:
20420250
19.

Opioids and central sensitisation: II. Induction and reversal of hyperalgesia.

Ruscheweyh R, Sandkühler J.

Eur J Pain. 2005 Apr;9(2):149-52. Review.

PMID:
15737805
20.

In response.

Cho AR, Kwon JY, Kim C.

Anesth Analg. 2013 Oct;117(4):1022-3. No abstract available.

PMID:
24187690

Supplemental Content

Support Center